HER2 FISH test

Diagnostic Use

The HER2 (ERBB2) protein is expressed at a low level in normal cells, but over-expressed in 18-20% of breast cancers.

Patients with HER2 gene amplification are eligible for treatment with trastuzumab (Herceptin®), which targets HER2 and has proved remarkably effective in patients with a tumour over-expressing the protein, in both metastatic and adjuvant settings.

Department

Genetics - Cytogenetics

Delphic Registration Code

CTGN

Synonyms

ERBB2 FISH

Turnaround Time

10 days

Test Code

9033